United States S 5459: A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Status: Introduced in Senate (as of 2024-12-09)

State: United States · Session: 118 · Bill: S 5459

Sponsors: Marsha Blackburn

View United States S 5459 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.